‘This is an important health issue’: Patients, organizations increase pressure to fund ovarian cancer drug

There are new and growing calls to get a life-saving ovarian cancer treatment funded in Canada and those taking on this fight say it underscores a much larger problem in this country.

As CityNews previously reported, negotiations failed to find a way for public health plans to fund Elahere (mirvetuximab soravtansine).

It’s designed specifically for women […] ...